Plastoform able to operate as going concern, company tells SGX

  • 📰 BusinessTimes
  • ⏱ Reading Time:
  • 25 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 51%

Italia Notizia Notizia

Italia Ultime Notizie,Italia Notizie

Plastoform able to operate as going concern, company tells SGX.

AUDIO-SPEAKER maker Plastoform Holdings' board said on Wednesday it believes that the company will be able to operate as a going concern and is in discussions about fundraising options, including a rights issue exercise, to obtain additional funding for working capital needs.It added that the firm will also borrow money if needed. The company also said it believes its licence business with Monster Inc will possibly lead to more product types and brands to the market in the future.

Plastoform was responding to Singapore Exchange's queries regarding its financials. It noted that the company is in a negative equity position of HK$0.89 million and has negative working capital of HK$1.35 million as at Dec 31, and has generated negative cash flow from operating activities of HK$1.87 million.It added:"The company still runs the original design manufacturing business and has also started new brand licencing sales with Monster logo with commencement in late-2018.

Abbiamo riassunto questa notizia in modo che tu possa leggerla velocemente. Se sei interessato alla notizia puoi leggere il testo completo qui. Leggi di più:

 /  🏆 15. in İT
 

Grazie per il tuo commento. Il tuo commento verrà pubblicato dopo essere stato esaminato.

Italia Ultime Notizie, Italia Notizie

Similar News:Puoi anche leggere notizie simili a questa che abbiamo raccolto da altre fonti di notizie.

Senators tell drug company executives pricing is 'morally repugnant'Seven drug company executives will testify about rising prescription drug prices before a powerful U.S. Senate Committee on Tuesday, marking a ...
Fonte: ChannelNewsAsia - 🏆 6. / 66 Leggi di più »

US senators tell drug company executives pricing is 'morally repugnant'Seven drug company executives will testify about rising prescription drug prices before a powerful U.S. Senate Committee on Tuesday, marking a ...
Fonte: ChannelNewsAsia - 🏆 6. / 66 Leggi di più »